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Background: Goal-directed therapy guidelines for pediatric septic shock resuscitation recommend fluid delivery at
speeds in excess of that possible through use of regular fluid infusion pumps. In our experience, syringes are
commonly used by health care providers (HCPs) to achieve rapid fluid resuscitation in a pediatric fluid
resuscitation scenario. At present, it is unclear which syringe size health care providers should use when
performing fluid resuscitation to achieve maximal fluid resuscitation efficiency. The objective of this study was
therefore to determine if an optimal syringe size exists for conducting manual pediatric fluid resuscitation.
Methods: This 48-participant parallel group randomized controlled trial included 4 study arms (10, 20, 30,
60 mL syringe size groups). Eligible participants were HCPs from McMaster Children’s Hospital, Hamilton,
Canada blinded to the purpose of the trial. Consenting participants were randomized using a third party
technique. Following a standardization procedure, participants administered 900 mL (60 mL/kg) of isotonic
saline to a simulated 15 kg child using prefilled provided syringes of the allocated size in rapid sequence.
Primary outcome was total time to administer the 900 mL and this data was collected through video review
by two blinded outcome assessors. Sample size was predetermined based upon a primary outcome analysis
using one-way ANOVA.
Results: 12 participants were randomized to each group (n=48) and all completed trial protocol to analysis.
Analysis was conducted according to intention to treat principles. A significant difference in fluid resuscitation
time (in seconds) was found between syringe size group means: 10 mL, 563s [95% CI 521; 606]; 20 mL, 506s
[95% CI 64; 548]; 30 mL, 454s [95% CI 412; 596]; 60 mL, 455s [95% CI 413; 497] (p<0.001).
Conclusions: The syringe size used when performing manual pediatric fluid resuscitation has a significant
impact on fluid resuscitation speed, in a setting where fluid filled syringes are continuously available. Greatest
efficiency was achieved with 30 or 60 mL syringes.
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Pediatric shock is a recognized medical emergency [1].
Aggressive fluid resuscitation is recognized as a critical
component of early non-cardiogenic shock management
[1-4]. The American College of Critical Care Medicine
(ACCM) guidelines for early goal-directed pediatric sep-
tic shock management recommend to, “Push boluses of
20 cc/kg isotonic saline or colloid up to & over 60 cc/kg
until perfusion improves or unless rales or hepatomegaly
develop” [4]. Clear pragmatic recommendations for
health care providers (HCPs) as to how to achieve rapid
fluid resuscitation are lacking in current guidelines. An
important aspect limiting fluid flow is that the intravenous
(IV) cannulas most commonly used in pediatric patients
have a small radius relative to those used in adults [5].
In adult patients, options for rapid fluid resuscitation
include rapid infuser devices and pressure bag support
[6-8]. While these modalities are available for use in
pediatric resuscitation, in our experience, syringes are
most commonly used for this purpose, likely due to their
relative availability and health care providers’ comfort
using them. A randomized controlled trial by Stoner et al.
determined that manual syringe and pressure bag methods
were an equivalent means of delivering fluid rapidly in an
emergency department setting [9]. However, in this study
only 58% of children resuscitated in the pressure bag and
68% in the syringe group met the ACCM benchmarks.
In the clinical setting, we have observed and health
care providers have endorsed two different manual syr-
inge techniques used for the purpose of rapid isotonic
fluid resuscitation for children in shock: 1) the ‘discon-
nect-reconnect’ technique and 2) the ‘push-pull’ tech-
nique [10]. When initiating manual fluid resuscitation
using syringes, a health care provider must make a deci-
sion regarding what syringe size to use. A larger syringe
has a larger radius relative to a given IV catheter. To create
the same pressure gradient (which is proportional to flow
rate) across an IV catheter, a health care provider must
apply a comparatively greater force to the plunger when a
larger syringe size is used, as dictated by the formula. F =
ΔP(πr2). Where the force applied is constant, a slower
fluid flow rate results when a larger radius syringe is used.1 2
Figure 1 The ‘disconnect-reconnect’ technique for rapid fluid resuscit
IV extension tubing, (2) administering the fluid manually, and then (3) disc
ready syringe that has been filled with fluid by an assistant, and repeatingWhen using the ‘disconnect-reconnect’ technique
(Figure 1) to perform manual fluid resuscitation, one
must also consider that total fluid administration time is
actually the sum of the “fluid push time” plus the “syringe
swap time”, as time is required to disconnect and replace
empty syringes with new fluid filled ones. Based on these
considerations, while the actual “fluid push time” may be
slower with use of larger syringes, it remains unclear
which syringe size is most efficient in terms of total fluid
administration time because the smaller syringes need
to be exchanged more frequently, proportionally increas-
ing the “syringe swap time”. Although the ‘disconnect-
reconnect’ technique is crude, it is commonly practiced
in our experience and interestingly not previously reported
in the literature. The objective of our study was therefore
to determine whether an optimal syringe size exists to fa-
cilitate rapid pediatric fluid resuscitation using the ‘discon-
nect-reconnect’ technique of manual fluid administration.
Methods
The study was a single-blind, non-clinical, parallel group
randomized controlled trial with four study arms. The
trial was conducted at McMaster Children’s Hospital, a
tertiary pediatric academic center in Hamilton, Canada.
Approval for study conduct was obtained from the Faculty
of Health Sciences/Hamilton Health Sciences Research
Ethics Board. Written informed consent was obtained
from all participants prior to participation. Although a
non-clinical trial, we elected to register this study at
www.ClinicalTrials.gov (NCT01494116). Conduct of this
trial was supported by funds obtained from the Department
of Pediatrics.
Study participants
Eligible participants included staff physicians, postgradu-
ate trainees, and nurses who were recruited by an e-mail
and poster campaign. We excluded non-English speak-
ing individuals and those incapable of performing man-
ual fluid administration with a syringe. Gift certificates
($25 coffee card) were offered to each subject as a par-
ticipation incentive. To further motivate peak perform-
ance among subjects, further prizes were awarded for3
ation. This method involves (1) connecting a fluid filled syringe to the
onnecting the empty syringe, thus allowing for connection of another
until fluid delivery is completed.
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pants were only allowed to participate on one occasion.
Randomization, allocation and blinding
Participants were assigned to one of four study arms, in
1:1:1:1 ratio, using a third party randomization technique.
The independent third party created the randomization
schedule using www.randomization.com and kept this se-
cret from and inaccessible to the investigators. Allocation
was therefore concealed. The randomization schedule uti-
lized permuted blocks of randomly varying size.
Participants were provided with details regarding the
trial sufficient to achieve informed consent however they
were not advised of the hypotheses of the investigators.
It was not possible to blind the research assistants, as
they needed to be familiar with the study protocol and
administer the intervention. Primary outcome assess-
ment was blinded in that the two individuals responsible
for extracting outcome data from the trial video record-
ings were not familiar with trial details or its purpose.
The outcome assessors were not advised of subject
group assignment and only had access to the study ID
number associated with a given video recording. They
were also unaware of other data collected as part of the
trial. Collected data was input by GH, with verification
by MP. The research assistants conducting the trial were
conceivably aware of the purpose of the trial (though
had no conflicts of interest with respect to the study
outcomes). All investigators had access to the raw data.
We therefore considered our trial as single-blind.
The model
The model in this study is best described as a low fidel-
ity simulator rendered “physiologic” in that it incorpo-
rated a 1.00-inch, 22-gauge IV catheter. Catheters of this
size are used clinically in newborn to adolescent age pa-
tients, making this a rational choice for our purposes.
Please see Additional file 1 for figures of the model and
a detailed description.
Intervention procedure
Following written consent, participants were randomized
to one of the four syringe size groups (10, 20, 30, or
60 mL). Upon receiving the participant group assign-
ment, a research assistant measured 900 mL of 0.9% nor-
mal saline using a graduated cylinder and then this was
divided into three 300 mL aliquots (each aliquot 20 mL/kg
based on a 15 kg simulated patient). Each aliquot was then
drawn up into colour-coded syringes of the assigned size,
with each of the three aliquots having a unique assigned
colour. Syringes of the same colour were then placed in
each of three kidney bowls.
To ensure adequate familiarity with study procedures
and the model prior to formal testing, all subjectsunderwent a standardization procedure [11]. This consisted
of a brief video orienting participants to the study setting
and demonstrating the ‘disconnect-reconnect’ technique.
Subjects were then provided with 3 fluid-filled demonstra-
tion syringes and given a brief opportunity to practice the
technique. Following this, subjects were verbally presented
with a clinical vignette of a febrile 15 kg toddler in decom-
pensated septic shock in need of immediate rapid fluid re-
suscitation. They were advised to administer the fluid
using the provided syringes as rapidly as possible, finishing
each 20 mL/kg colour set in sequence. Trials were com-
menced on verbal prompt by the research assistant and
proceeded without interruption.
All subject testing was video recorded in a manner
which captured the manual performance of fluid admin-
istration for outcome ascertainment purposes, but which
did not capture participant identifiers. In addition to
video recording all testing, the research assistant timed
with a stopwatch the initial two participant trials. Due to
clear inaccuracies with use of the stopwatch timing
method, we reverted to use of the trial video recordings
for outcome ascertainment as per our a priori plan. A
data collection form was completed by the research as-
sistant at the time of testing to record other secondary
outcomes of interest. Each participant also completed a
post-trial questionnaire.
Outcome measures and assessment
Fluid administration times (in seconds) were determined
from video review by two independent outcome asses-
sors blinded to the purpose of the trial. For each video,
the assessors were asked to determine four separate fluid
administration times based upon a clear, a priori defined
protocol to ensure consistency. A common software pro-
gram (Apple Quicktime™) was used to review the trial
videos and the time bar function was used to identify
times in the video frame sequence. Time outcomes
extracted included time to administer the full 900 mL
(60 mL/kg) of NS (primary outcome measure) and times
to administer each of the three 300 mL (20 mL/kg) aliquots
of NS, (secondary outcome measure). For the purposes of
final data analysis, the times of the two independent asses-
sors were averaged for each outcome of interest.
Descriptive data regarding the characteristics of partic-
ipants were ascertained from the post-trial question-
naire. The questionnaire also asked participants to recall
and rate their level of fatigue following each 20 mL/kg
bolus on a 7-point Likert scale. Catheter dislodgement
events (defined as physical displacement/removal from
the conduit tubing) were noted by the research assistant
during testing and on the data collection form. The vol-
ume of normal saline actually received by the model was
determined by the research assistant by measuring the
amount of fluid collected in the graduated cylinder.
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The analysis results of subject baseline characteristics
and outcome variables (both primary and secondary)
were summarized using descriptive summary measures:
expressed as mean (standard deviation) or median (mini-
mum-maximum) for continuous variables and number
(percent) for categorical variables. Final statistical ana-
lyses were performed using SAS (SAS Institute Inc.,
Cary, NC, USA), although SPSS (IBM Corporation,
Armonk, NY, USA) was used for some preliminary ana-
lyses and figure generation.
The primary outcome was analysed using a One-way
ANOVA analysis, with post hoc comparison of syringe
group total intervention time means using Tukey’s HSD.
Secondary outcome analyses consisted of Generalized
Linear Model (GLM) with repeated measures in order to
compare bolus administration times and fatigue scores
for each of the three sequential aliquots. We planned to
use Chi-square testing to compare the proportion of
catheter dislodgement events by syringe size group.
One-way ANOVA was used to compare the meanAssessed for elig
Allocated to 10 mL 
syringes (n= 12)
Participated (n=12)
Allocated to 20 mL 
syringes (n= 12)
Participated (n=12)
Randomized
Analysed (n=12) Analysed (n=12)
Figure 2 The Pediatric Fast Fluid Trial flow diagram. No participants w
protocol to analysis. Initial allocation called for 1:1:1:1 syringe size distributio
30 mL group from the 60 mL group. This same subject was analysed as pe
change in primary outcome.volume of normal saline received by the model according
to syringe size group. A two-way random effects model was
used to compare the agreement of our blinded outcome as-
sessors (both observer and subject were treated as random
effects) [12].
The 48 subject sample size for the trial was deter-
mined a priori based upon the planned One-way
ANOVA primary outcome analysis. Sample size calcula-
tions utilized an estimated effect size, determined based
upon preliminary testing in the model. Using a signifi-
cance level of 0.05 and power of 80%, the sample size
needed for the trial was conservatively estimated at 12
subjects in each group, 48 total.
Results
Forty-eight participants were recruited from October
2011 to December 2011 with no excluded participants.
The process of subject selection and flow throughout
the study is summarized in a flow-diagram in accord-
ance with the CONSORT Statement (Figure 2) [13,14].
Notably, one participant who should have been assignedibility (n= 48)
Excluded  (n=0)
Allocated to 30 mL 
syringes (n= 12)
Allocated to 60 mL 
syringes (n= 12)
Participated (n=13) Participated (n=11)
 (n= 48)
Analysed (n=12) Analysed (n=12)
1
1
ere excluded from initial 48 subject recruitment. All subjects completed
n, however one subject was mistakenly allocated to participate in the
r protocol in the 60 mL group after per protocol analysis showed no
Figure 3 Preferred techniques of rapid fluid resuscitation as
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sequence was incorrectly allocated to and received
the 30 mL assignment due to a communication error.
This individual was analyzed in the 60 mL group as per
intention to treat principles but we also conducted a per
protocol analysis of the primary outcome to assess for any
potential impact this may have had on the primary out-
come. The per-protocol analysis failed to show any differ-
ence in the primary outcome analysis result. Further
study analyses were therefore conducted using only an
intention-to-treat analysis.
Baseline demographics of the participants as gathered
from the post-intervention questionnaire are seen in
Table 1. Participants indicated that they were most com-
fortable using the ‘disconnect-reconnect’ technique as
their preferred method of fluid administration for chil-
dren in shock (48%), though many also preferred the
‘push-pull’ technique (27%); regular infusion pump was
also preferred by 14% (Figure 3). Respondents were
asked to choose one preferred method, however severalreported by participants. The majority of respondents reported
preference for the ‘disconnect-reconnect’ technique of fluid
bolusing. The next most commonly cited preference was the ‘push-
pull’ technique, and 8/48 participants reported preference for a
regular infusion pump – an unacceptable means of delivering a fluid
bolus in a resuscitation scenario. Legend: gray, Pressure bag; red,
Disconnect-Reconnect technique; green, Push-Pull technique; violet,
Regular infusion pump; blue, Don’t know/no answer; orange, More
than one preferred technique.
Table 1 Baseline demographics of trial participants
Variable Syringe group Total
10 20 30 60
Age Range
>50 1 1 0 0 2
40-49 1 2 4 2 9
30-39 2 6 5 6 19
20-29 8 3 3 4 18
Profession
Nurse 5 9 5 7 26
Nursing Student 1 0 0 0 1
Resident 4 1 4 4 13
Staff Physician 2 2 3 1 8
Fluid Resuscitation Experience
None 2 0 2 0 4
Minimal 3 0 1 2 6
Some 2 2 2 3 9
Experienced 1 6 2 3 12
Very Experienced 4 4 5 4 17
*Use Syringes for Fluid Resuscitation
Yes 10 9 8 11 38
No 0 3 1 1 5
Don’t Know 0 0 1 0 1
*Use ‘disconnect-reconnect’ Technique
Yes 7 9 8 11 35
No 3 3 0 0 6
Don’t Know 0 0 2 1 3
*Answers were not asked of four participants whom wrote ‘none’ to fluid
resuscitation experience.circled more than one answer on their post-test ques-
tionnaire (48 subjects provided 54 responses). Four re-
spondents did not provide an answer.
The primary outcome of total fluid delivery time sig-
nificantly differed according to syringe size based on our
analysis with one-way ANOVA at p = 0.0012 (Table 2).
Post Hoc analysis with Tukey’s HSD demonstrated a sig-
nificant difference in fluid administration time when
comparing the 10 mL group to both the 30 mL and
60 mL groups respectively (Table 3). There did appear
to be a trend towards superiority of the 30 mL and
60 mL groups over the 20 mL group, but this was
not statistically significant (Figure 4).Table 2 Total mean fluid bolus times and mean rates
with 95% confidence intervals by syringe size grouping
Syringe
group
N Mean
time (s)
95% CI Mean rate
(mL/s)
95% CI
10 12 563.50 [521.43, 605.57] 1.62 [1.47, 1.78]
20 12 506.42 [464.34, 548.49] 1.81 [1.66, 1.97]
30 12 454.42 [412.34, 496.49] 2.04 [1.89, 2.19]
60 12 454.92 [412.84, 496.99] 1.99 [1.84, 2.14]
One-way ANOVA between groups significant at p = 0.0012.
Mean rates reported for comparison sake to other literature.
Table 3 Tukey HSD comparison testing of syringe group
mean total bolus times
Syringe group: Comparison group: Significance (p-value)
10 20 0.228
30* 0.003
60* 0.003
20 10 0.228
30 0.306
60 0.315
30 10* 0.003
20 0.306
60 1.000
60 10* 0.003
20 0.315
30 1.000
* - The mean difference is significant at the 0.05 level by Tukey HSD
test comparison.
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ber detected an interaction between syringe size and
bolus number (Figure 5). As a consequence, we are un-
able to report the main effect related to this outcome of
interest. The GLM analysis, with Greenhouse-GeisserFigure 4 Mean fluid bolus times by syringe size with 95% confidence
between 10 mL and 30/60 mL syringe size groups is clearly demonstrated.
groups over the 20 mL group, but this did not achieve significance. This tr
use of 35–60 mL syringes for optimal fluid resuscitation [1].correction, for HCP self-reported fatigue by bolus number
did differ significantly across bolus 1, 2, and 3 (F 120.19,
p<0.0001). There was no significant interaction in this
analysis (Figure 6). Syringe size did not have a statistically
significant impact on fatigue scores (p=0.51).
The total amount of fluid received by the model as a
result of resuscitation was not significantly different be-
tween syringe size groups (p=.177) (Table 4). There were
no catheter dislodgement events and so this outcome
was not analyzed. Excellent agreement was found be-
tween the two blinded outcome assessors based on the
total fluid administration time data extracted from the
trial video recordings (ICC=0.99997).Discussion
This trial demonstrates a significant impact of syringe
size on fluid administration time in a study setting in-
volving health care provider subjects and a non-clinical
pediatric fluid resuscitation model. Our results suggest
that the use of larger syringe sizes (30 mL or 60 mL) is
most efficient and dissuades the use of 10 mL syringes
in situations where rapid pediatric fluid resuscitation is
required. While the 20 mL syringe size was not statisti-
cally inferior to the 30 and 60 mL sizes, there was aintervals (primary outcome analysis). Significant difference
There is a notable trend of superiority between of the 30/60 mL
end provides empirical validity to PALS recommendations suggesting
Figure 5 A Fluid infusion time by syringe size group. In the GLM
analysis an interaction was found between syringe size group and bolus
number that precluded comment on the impact of bolus number on fluid
infusion time. This outcome was intended to determine whether
progressive fatigue objectively occurred among providers with repeated
fluid bolus administration. A: blue, First 20 mL/kg normal saline bolus; green,
Second 20 mL/kg normal saline bolus; red, Third 20 mL/kg normal saline
bolus. B Fluid infusion time by bolus number. This figure assists with
understanding why the interaction between syringe size and bolus number
is occurring. It appears that the 10 mL syringe size group “speeds up” in
terms of the time to administer sequential 20 mL/kg fluid boluses while the
larger syringe size groups appear to “slow down”. The 10 mL group likely
“sped up” because providers became more efficient at rapidly disconnecting
and reconnecting syringes. B: blue, 10 mL syringe group; green, 20 mL
syringe group; red, 30 mL syringe group; violet, 60 mL syringe group.
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did not statistically differ from the 10 mL group.
We had hypothesized that HCPs would objectively fa-
tigue over the course of performing the intervention as
borne out by differences in the administration times of
boluses 1, 2, and 3. We were unable to confirm or refute
this hypothesis due to the presence of an interaction that
precluded assessment of the main effects in this analysis.
There was, however, a statistically significant increase in
HCP self-reported fatigue with successive fluid boluses.
Examining our results graphically by syringe group, it
appears as if there is a trend toward increased self-
reported fatigue among providers using the 60 mL syr-
inge size (Figure 6). This makes sense with what we
know about the physics and physiology: it is physically
more difficult for providers to depress the syringe plun-
ger of fluid filled syringes of a larger diameter.
While the presence of an interaction prevented us
from assessing an impact on fluid administration time
by bolus number, the interaction graph is itself interest-
ing and somewhat instructive (Figure 5). The interaction
appears to have occurred because the 10 mL group
seemed to “speed up” with time, while the other 3 syr-
inge size groups appear to have slowed down with on-
going fluid resuscitation. One hypothesis that may be
generated from this finding is that individuals in the
10 mL group may have become more efficient at
connecting and disconnecting the syringes over the course
of the intervention. Because the 10 mL group had the
greatest number of syringes to connect and disconnect for
each bolus, proportionally speaking, the time allocated to
disconnecting and reconnecting syringes was greatest for
this group. In contrast, the observation that the other syr-
inge size groups appeared to slow down with time would
fit with our a priori hypothesis of provider fatigability.
Our finding of progressive subjective fatigue among
trial participants is certainly noteworthy and not previ-
ously reported in the literature. In other physically
strenuous resuscitative tasks, such as the performance of
chest compressions (CPR), current best practices involve
frequent provider switches to avoid performance decay
[15]. We suggest that given how fatiguing rapid manual
fluid administration can be, perhaps routine provider
switches are warranted for this resuscitation task as well.
This issue is not addressed in current resuscitation
guidelines. A logical time for provider switches would be
between 20 mL/kg boluses.
The finding that a number of our study participants
believed that regular infusion pumps were an adequate
pediatric fluid resuscitation method underscores that
more education is needed for HCPs regarding optimal
fluid resuscitation performance. We still encounter
standard IV pumps being inappropriately utilized in the
setting of shock. Such pumps provide a maximum fluid
Syringe Size Group (mL)
60302010
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1
Figure 6 Mean fatigue score with 95% confidence interval by syringe size group and bolus number. Increased fatigue scores correlated
significantly with bolus number in each syringe group by GLM analysis. This provides a subjective basis for our recommendation to consider
provider changes during a fluid resuscitation. Legend: ●First 20 mL/kg normal saline bolus; ▲Second 20 mL/kg normal saline bolus; ■Third
20 mL/kg normal saline bolus.
Table 4 Total mean cylinder volumes with 95% confidence
intervals by syringe group
Syringe group N Mean volume: (mL) 95% CI
10 12 872.92 [866.795, 879.039]
20 12 872.22 [866.211, 878.455]
30 12 870.75 [864.628, 876.872]
60 12 864.25 [858.128, 870.372]
One-way ANOVA between groups not significant at p = 0.1771.
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insufficient to achieve ACCM benchmarks. For example,
for a 15 kg child, as simulated by our model, a 20 mL/kg
bolus would take 18 minutes to infuse with use of a
regular IV pump. As such pumps are often the most
convenient means to operationalize a fluid bolus order,
it is imperative for the physicians writing such orders to
be explicit regarding the intended time frame and
method of administration.
There are several limitations to our trial that warrant
mention. Firstly, in a real resuscitation, syringes are not
neatly prepared as was the case in our trial. However,
with use of the ‘disconnect-reconnect’ method, syringes
are typically prepared quickly by one or more HCPs
resulting in a similarly “limitless” supply - that often ac-
cumulates. Second, while use of a crossover design may
have been preferable, with 4 intervention groups, we felt
that use of this design would negatively impact on feasi-
bility and increase the risk of participant dropout. We
are satisfied that participants’ characteristics appear well
balanced across the groups in our study. Thirdly, no
catheter dislodgement events were recorded in our trial.
It is possible that features attributable to our model had
a protective effect against catheter dislodgement, al-
though this was indeed possible and occurred during
pilot testing. In this context, it is notable that only 1/57
subjects in the clinical trial performed by Stoner et al. ex-
perienced a catheter failure [9]. Finally, our trial protocol
did not strictly adhere to ACCM guideline insofar as“patient” reassessments between each 20 mL/kg bolus are
recommended [4]. In our experience, these reassessments
often do not slow HCPs from administering fluid where
ongoing resuscitation in required and such assessments
are often done concurrently.
Although our study was conducted in the non-clinical
setting, we had typical health care providers perform rapid
fluid administration as they would under resuscitative
conditions. The model incorporated an IV catheter and so
resistance to fluid flow was as it would be in the clinical
setting. Further, infants and children with decompensated
shock, as in our clinical vignette are typically lethargic and
so patient movement may not be all that dissimilar to our
model. We therefore believe that our findings can likely
be cautiously extrapolated to the clinical setting.
Our conclusions, and any other optimizations to be
made in rapid fluid resuscitation relate to statistically
significant differences in the order of seconds to mi-
nutes. Therefore, ultimately demonstrating whether
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ance have an impact on patient important outcomes
like morbidity and mortality may be difficult. Nonethe-
less, observational studies have provided the basis for
current goal-directed ACCM benchmarks, [16,17] and
subsequent prospective studies have shown morbidity
and mortality benefit with adherence to these [18,19].
Morbidity and mortality related to pediatric septic
shock has dropped significantly in recent decades –
owing in part to improved recognition and aggressive
management, of which fluid resuscitation is currently
considered a critical component [20,21]. While studies
such as the FEAST trial [22] have begun to raise ques-
tions regarding the role and extent of fluid resuscitation
in the treatment of septic shock, the purpose of our
study was not to challenge current ACCM guidelines,
for which support has recently been reaffirmed [23]. In-
stead, we sought to evaluate and improve upon imple-
mentation, which is known to be problematic [17-19].
Furthermore, the need to increase clarity and pragmatic
instruction for health care providers regarding how best
to perform fluid resuscitation is relevant to the manage-
ment of all forms of non-cardiogenic shock.
Conclusions
Our results support use of 30 and 60 mL syringes for
the purposes of rapid pediatric fluid resuscitation when
the ‘disconnect-reconnect’ technique is utilized. Further
studies are needed to evaluate the comparative efficiency
of other fluid resuscitation techniques, the potential prob-
lem of provider fatigability, and how fluid resuscitation is
best performed in the context of multi-provider teams. An
improved body of evidence should assist with generating
clear best practice recommendations as to how pediatric
fluid resuscitation is best performed.
Key messages
1) When using a syringe for pediatric fluid
resuscitation, choose a 30 – 60 mL syringe.
2) Regular infusion pumps are not adequate for
performing fluid resuscitation for children in shock.
3) Further studies are needed to support comprehensive
and pragmatic recommendations regarding best
practice pediatric fluid resuscitation techniques.
Additional file
Additional file 1: Detailed Model Description and Figures. Text
description of model and two representative figures (photos and schematic).
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